Conferences Plot a Comeback Even Before Vaccines Are Widely Distributed
Bloomberg 12/23/2020 Sarah McBride
(Bloomberg) It could take a while before the handshake comes back, if it ever does. Business conferences, however, are set to restart in the U.S. the moment health code allows. And despite uncertainty around when exactly that will be, convention organizers are holding out hope and event space for a possible return in the coming weeks.
One of those optimists is Peter Diamandis. He convened some of his employees at their office in Culver City, California, last Wednesday for a low-key, in-person holiday gathering. There, Diamandis said his flagship annual conference, Abundance 360, was still on for late January in Malibu, California, according to a person familiar with the situation who asked not to be identified. It will feature seminars on technology and entrepreneurialism, as well as a video address from Salesforce.com Inc.’s Marc Benioff.
Какие вакцины от коронавируса заказала Украина strana.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from strana.ua Daily Mail and Mail on Sunday newspapers.
Medigen applies for phase 2 COVID-19 vaccine trial
Staff writer, with CNA
Medigen Vaccine Biologics Corp (高端疫苗) has applied to begin phase 2 testing of its COVID-19 vaccine, becoming the third local developer to seek permission to test the efficacy of its product on a larger scale, following Adimmune Corp (國光生技) and United Biomedical Inc (聯亞生技).
All participants in its phase 1 trial had completed the two-dose regimen of the vaccine, allowing researchers to obtain data on its safety and ability to elicit an immune response, Medigen said in a statement on Tuesday.
The company said that it had applied to the Food and Drug Administration for permission to begin phase 2 clinical trials to test the vaccine’s efficacy on 3,700 volunteers.